Neuphoria Therapeutics Inc. (NASDAQ:NEUP) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Spyros Papapetropoulos Other companies: Lipocine Inc. (Director · Since at least Apr 11, 2022); Vigil Neuroscience Inc (Chief Medical Officer · Jan 6, 2022 – Nov 18, 2022 · Past); Adamas Pharmaceuticals Inc (Director · Nov 22, 2020 – Nov 24, 2021 · Past) | President and CEO, Director · Since at least Jul 1, 2024 |
| Timothy M Cunningham Other companies: Rein Therapeutics, Inc. (See Remarks · May 16, 2024 – May 16, 2024 · Past); Alaunos Therapeutics, Inc. (interim CFO · Feb 17, 2021 – Feb 17, 2021 · Past); Organogenesis Holdings Inc. (Chief Financial Officer · Dec 10, 2018 – Apr 22, 2020 · Past) | Chief Financial Officer · Jul 1, 2024 – Jul 1, 2024 · Past |
| Aaron N. D. Weaver Other companies: Interactive Strength Inc. (Non-Employee Director · Since at least Apr 27, 2023) | Director · Jul 1, 2024 – Jul 1, 2024 · Past |
| Tim Cunningham Other companies: Rein Therapeutics, Inc. (Interim Chief Financial Officer · Since at least Nov 4, 2026) | Fractional CFO · Since at least Nov 4, 2026 |
| Alan Fisher | Non-Executive Chairman · Since at least Jul 1, 2024 |
| David Wilson | Non-Executive Director · Since at least Jul 1, 2024 |
| Jane Ryan | Non-Executive Director · Since at least Apr 16, 2025 |
| Miles Davies | Non-Executive Director · Since at least Dec 8, 2025 |
| Peter Miles Winston Davies | Director · Since at least Jul 1, 2024 |
| Spyridon Papapetropoulos | IR & PR · Since at least Dec 8, 2025 |